eli lilly tirzepatide patent | US Patents | Expiry | Expiration Eli Lilly's tirzepatide showed positive
Description
Some patients also report nausea or GI discomfort when dosing intervals become irregular
Post-injection window : Many patients report that nausea may be more noticeable in the days following each weekly injection, gradually improving as the week progresses
While breakouts may show
You're learning what works for you
